Navigation Links
A*STAR scientists discover novel hormone essential for heart development
Date:12/6/2013

1. Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.

2. The team led by Dr Bruno Reversade carried out experiments to determine ELABELA's function, since its existence was hitherto unsuspected. Using zebrafish designed to specifically lack this hormone, they uncovered that ELABELA is indispensable for heart formation. Zebrafish embryos without this gene had rudimentary or no heart at all (see Figure 1). Their results were published in the 5 December 2013 online issue of Developmental Cell.

3. Deficiencies in hormones are the cause of many diseases, such as the loss of insulin or insulin resistance, that results in diabetes, and irregularities in appetite and satiety hormones that can cause obesity. Hormones are known to control functions such as sleep, appetite and fertility. However, this is the first time that scientists have revealed the existence of a conserved hormone playing such an early role during embryogenesis, effectively orchestrating the development of an entire organ.

4. The team also found that ELABELA uses a receptor previously believed to be specific to APELIN, a blood-pressure controlling hormone. This receptor called APJ or Apelin Receptor has dual functions - it first conveys signals from ELABELA and then from APELIN. Mutations in the Apelin Receptor also prevent the heart from forming. Zebrafish bereft of the Apelin Receptor are referred to as the Grinch, in reference to the cold and heartless cartoon character created by Dr. Seuss in 1957.

5. ELABELA has also been found to be expressed in human embryonic stem cells , indicating that it might have other functions beyond its role in cardiovascular development.

6. The team's findings hold great promise for the potential use of ELABELA as a therapeutic molecule for cardiovascular disease to be used in cardiac repair and control of hypertension. As some people might have a harmful copy of the ELABELA gene in their genetic make-up, sequencing and screening for this particular gene in the general population might also help to detect predisposition to heart anomalies before the disease progresses.

7. Dr Bruno Reversade said, "The human genome has been sequenced over a decade ago. That we can still find anonymous hormones charms me. There are a still a few more to discoverbut not for long."

8. Prof Birgitte Lane, Executive Director of IMB, said, "This discovery shows great promise for the development of targeted therapies for heart disease and blood pressure control in the future. It is an excellent example of how basic research can lead to surprising and unexpected findings that may change and refine medical practice."

9. Prof Hong Wan Jin, Executive Director of IMCB, said, "I am very pleased with Bruno's achievement as it reflects the synergy of collaboration and joint efforts among various research institutes in Singapore."


'/>"/>

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert  

Related biology news :

1. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
2. A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans
3. A*STAR scientists discover potential drug for deadly brain cancer
4. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
5. Scientists unearth secrets of Périgord truffles, the culinary black diamond
6. Top scientists to present at Epigenetic Control and Cellular Plasticity symposium
7. Salk scientists crack riddle of important drug target
8. Scientists stitch up photosynthetic megacomplex
9. Scripps Research Institute scientists achieve most detailed picture ever of key part of hepatitis C
10. UCLA research may help scientists understand what causes pregnancy complications
11. Scientists discover how leukemia cells exploit enhancer DNA elements to cause lethal disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A*STAR scientists discover novel hormone essential for heart development
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):
(Date:8/23/2017)... ... August 23, 2017 , ... ... academic medical centers. The network provides members nationally scaled infrastructure and support to ... and restrictive payer agreements so members can provide continuity of care for their ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... upon patented KBioBox technology, the extended GUIDE-Seq ananlysis. KBioBox has adapted their core ... to be provide scientists with easy to understand reports, extended indel analysis, and ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... The awards recognize medical centers that have implemented innovative products, services, and technology ... care protocols, competitive advantages, financial impact/value, and market need. The applicants with the ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
Breaking Biology Technology: